| P50 | author | Il-Sun Kim | Q61105408 |
| | Kwangsoo Jung | Q85939765 |
| P2093 | author name string | Kook In Park | |
| | Il-Shin Lee | |
| P2860 | cites work | Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. | Q24534130 |
| | Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway | Q24558745 |
| | Induction of neurogenesis in the neocortex of adult mice | Q28139868 |
| | Multipotent neural cell lines can engraft and participate in development of mouse cerebellum | Q28290006 |
| | Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system | Q28292445 |
| | Direct isolation of human central nervous system stem cells | Q28318408 |
| | Mammalian neural stem cells | Q29547657 |
| | Chemokines: a new classification system and their role in immunity | Q29615663 |
| | Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1 | Q29616092 |
| | Tissue engineering | Q29617288 |
| | Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells | Q30476168 |
| | Neural stem cell heterogeneity demonstrated by molecular phenotyping of clonal neurospheres | Q33184870 |
| | Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury | Q33202586 |
| | Establishment and properties of neural stem cell clones: plasticity in vitro and in vivo | Q33693785 |
| | Transplantation of neural progenitor and stem cells: developmental insights may suggest new therapies for spinal cord and other CNS dysfunction | Q33746547 |
| | Cell replacement therapies for central nervous system disorders. | Q33921503 |
| | Segregation of human neural stem cells in the developing primate forebrain | Q34085142 |
| | Neural stem cells in the developing central nervous system: implications for cell therapy through transplantation | Q34120712 |
| | The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue | Q34154476 |
| | Can stem cells cross lineage boundaries? | Q34205516 |
| | Isolation, Characterization, and use of Stem Cells from the CNS | Q34299470 |
| | Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations | Q34425181 |
| | Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. | Q34433743 |
| | Global gene and cell replacement strategies via stem cells | Q34658436 |
| | Stem cells: cross-talk and developmental programs | Q35213974 |
| | Taking stock and planning for the next decade: realistic prospects for stem cell therapies for the nervous system | Q35719538 |
| | Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. | Q35850739 |
| | "Global" cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain | Q36389958 |
| | The therapeutic potential of neural stem cells | Q36500191 |
| | Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex | Q36605438 |
| | A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. | Q37089440 |
| | Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. | Q37416265 |
| | Development of biocompatible synthetic extracellular matrices for tissue engineering | Q38551581 |
| | Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates | Q40339968 |
| | Cortical development: View from neurological mutants two decades later | Q40441433 |
| | Genetically perpetuated human neural stem cells engraft and differentiate into the adult mammalian brain | Q40758370 |
| | DNA delivery from polymer matrices for tissue engineering | Q40945294 |
| | Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation | Q40962528 |
| | Tissue engineering: from biology to biological substitutes | Q40988634 |
| | Stem cells in the central nervous system | Q41116811 |
| | Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells | Q41180628 |
| | Reversal of age-dependent cognitive impairments and cholinergic neuron atrophy by NGF-secreting neural progenitors grafted to the basal forebrain. | Q41316689 |
| | CNS-derived neural progenitor cells for gene transfer of nerve growth factor to the adult rat brain: complete rescue of axotomized cholinergic neurons after transplantation into the septum. | Q41317097 |
| | Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain | Q41358776 |
| | Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer | Q41741592 |
| | Limitations in brain repair | Q44121363 |
| | Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: Evidence from engraftment of Neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury | Q45858514 |
| | BDNF gene transfer to the mammalian brain using CNS-derived neural precursors | Q45864059 |
| | Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. | Q45890216 |
| | Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. | Q46695611 |
| | In vitro expansion of a multipotent population of human neural progenitor cells | Q48156909 |
| | Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis | Q48332405 |
| | CXCR4 is a major chemokine receptor on glioma cells and mediates their survival | Q48464729 |
| | Acute injury directs the migration, proliferation, and differentiation of solid organ stem cells: evidence from the effect of hypoxia-ischemia in the CNS on clonal "reporter" neural stem cells | Q48515817 |
| | Human neurospheres derived from the fetal central nervous system are regionally and temporally specified but are not committed | Q48530443 |
| | Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease. | Q48586630 |
| | Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell | Q49011276 |
| | Chemokine signaling: rules of attraction. | Q52108335 |
| | Functions of basic fibroblast growth factor and neurotrophins in the differentiation of hippocampal neurons | Q71909036 |
| | Distinct roles for bFGF and NT-3 in the regulation of cortical neurogenesis | Q71909087 |
| | Chemokine receptors | Q74481121 |
| | The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment | Q77402792 |
| | "Is there any need to argue..." about the nature and genetic signature of in vitro neural stem cells? | Q83893556 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| | neural stem cell | Q2944097 |
| P304 | page(s) | 855-865 | |
| P577 | publication date | 2010-12-01 | |
| P1433 | published in | Pediatrics International | Q7159237 |
| P1476 | title | Neural stem cells: properties and therapeutic potentials for hypoxic-ischemic brain injury in newborn infants | |
| P478 | volume | 52 | |